Market Update. Key week ahead and new all-time highs

On Monday, October 27, 2025, U.S. stock futures kicked off the week on a decidedly positive note, with the S&P 500 futures rising by approximately 0.7% in pre-market trading. This buoyancy is setting the stage for what analysts expect to be a strong week following the record-setting closing highs of the S&P 500, Nasdaq, and Dow Jones indexes last Friday.[…]

Read more

Ethereum and the Russell 2000 Index. A Tale of Two Market Movers in 2025

In 2025, Ethereum (ETH) has demonstrated price movements and market behavior remarkably similar to those of the Russell 2000, the US small-cap stock index. This unexpected correlation is gaining the attention of investors and analysts alike as both assets soar on the back of anticipated Federal Reserve interest rate cuts, supportive technical patterns, and strong fundamentals. BlackRock’s Cryptocurrency ETF Leadership[…]

Read more

NIO Stock. A Deep Dive into Recent Wall Street Optimism and Future Prospects

NIO Inc., a prominent Chinese electric vehicle (EV) manufacturer, has recently captured Wall Street’s attention with a notable shift in institutional investor sentiment and significant target price upgrades from major financial institutions. Trying to analyze the drivers behind this renewed optimism, the key upcoming events in September, and the factors sustaining the current rally, alongside the risks investors should watch[…]

Read more

The Incredible AI Bubble of 2025. An Economic Curious Perspective and Some Thoughts

The global financial markets in 2025 are witnessing what many experts now term an unprecedented “The Incredible AI Bubble of 2025… Or, better, the Everything Bubble.” This bubble spans multiple asset classes—stocks, housing, cryptocurrencies, and bonds—reflecting extreme overvaluation and fragility reminiscent of past manias but magnified in scale and complexity. The term “Everything Bubble” itself captures a zeitgeist of broad[…]

Read more

Oscar Health. Why I See Only Upside From Here

Oscar Health, Inc. (NYSE: OSCR), a technology-driven health insurance company, has long divided Wall Street analysts. While some see a speculative bet with unsustainable losses, others — like myself — view it as a misunderstood growth story with the potential to deliver exponential returns. If Oscar’s operational fears dissipate, and its valuation multiples expand to align with sector peers, I[…]

Read more